Smruthi Organics Limited share price
BSE: SMRUTHIORG
Key numbers
- Market cap
- ₹ 185 Cr
- Current price
- ₹ 162.05
- 52-week high / low
- ₹ 175 / 95
- Stock P/E
- 25.0
- Book value
- ₹ 64.2
- Dividend yield
- 0.93%
- ROCE
- 6.4%
- ROE
- 4.7%
- Debt to equity
- 0.12
- Sales growth (3 yrs)
- -10.5%
- Profit growth (3 yrs)
- -6.0%
- 1-year return
- 15.1%
About Smruthi Organics Limited
Smruthi Organics Limited manufactures and markets active pharmaceutical ingredient (API) products to India. The company operates through Bulk Drugs and Drugs Intermediates (API), and Formulation segments. The company provides API for cardiovascular, such as amlodipine besilate, losartan potassium, telmisartan, s - amlodipine besilate, s - amlodipine malelate, and valsartan; for anti diabetic, which comprises metformin HCL, vildagliptin, teneligliptin, and dapagliflozin; and for anti infectives that consists of diloxanide furoate, norfloxacin, and pefloxacin mesylate, as well as ticagrelor for anti platelets. It also offers drug intermediates, such as amlodipine base, s-amlodipine base, and phthaloyl amlodipine. In addition, the company is developing empagliflozin for anti-diabetics; and apixaban and rivaroxaban for anti-platelets. It also exports its products. The company was incorporated in 1989 and is headquartered in Solapur, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 19 | 32 | 22 | 29 | 29 |
| Operating profit | 0 | 5 | 4 | 4 | 6 |
| Net profit | -1 | 2 | 1 | 1 | 3 |
| EPS (₹) | -0.96 | 1.80 | 1.22 | 0.93 | 2.51 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.